Nymirum
Dr. Pape is a co-founder of Nymirum and is a serial biotech entrepreneur and experienced executive. He previously co-founded Esperion Therapeutics (sold to Pfizer for $1.3B in 2004), and launched Orchard Venture Partners, Akebia and Aerpio with JP. He is also a veteran of large pharma as a scientist at Upjohn, Parke-Davis, and Pfizer, directing drug discovery and development. He was instrumental to the R&D of the blockbuster Lipitor.
Dr. Pape is a Distinguished Alumni of both the University of Chicago Booth School of Business, where he received his MBA, and Purdue University where he received his PhD in Biochemistry.
This person is not in any offices
Nymirum
Nymirum exploits the dynamics and atomic-scale structure of RNA to guide novel small molecule drug discovery.